nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—NPY1R—Peptide ligand-binding receptors—SST—duodenum cancer	0.0562	0.0562	CbGpPWpGaD
Atomoxetine—NPY1R—G alpha (i) signalling events—SST—duodenum cancer	0.0475	0.0475	CbGpPWpGaD
Atomoxetine—HTR6—G alpha (s) signalling events—SCT—duodenum cancer	0.0404	0.0404	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR ligand binding—SCT—duodenum cancer	0.0397	0.0397	CbGpPWpGaD
Atomoxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.0377	0.0377	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR ligand binding—SST—duodenum cancer	0.0287	0.0287	CbGpPWpGaD
Atomoxetine—SLC6A4—SIDS Susceptibility Pathways—SST—duodenum cancer	0.0258	0.0258	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR downstream signaling—GAST—duodenum cancer	0.0237	0.0237	CbGpPWpGaD
Atomoxetine—HTR2C—G alpha (q) signalling events—GAST—duodenum cancer	0.0226	0.0226	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR downstream signaling—SCT—duodenum cancer	0.0225	0.0225	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—GAST—duodenum cancer	0.0215	0.0215	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—SCT—duodenum cancer	0.0204	0.0204	CbGpPWpGaD
Atomoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.0202	0.0202	CbGpPWpGaD
Atomoxetine—HTR2A—G alpha (q) signalling events—GAST—duodenum cancer	0.0196	0.0196	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—duodenum cancer	0.0175	0.0175	CbGpPWpGaD
Atomoxetine—HTR1D—G alpha (i) signalling events—SST—duodenum cancer	0.0174	0.0174	CbGpPWpGaD
Atomoxetine—HTR1B—G alpha (i) signalling events—SST—duodenum cancer	0.017	0.017	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR downstream signaling—SST—duodenum cancer	0.0162	0.0162	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—SST—duodenum cancer	0.0155	0.0155	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—SST—duodenum cancer	0.0147	0.0147	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—SCT—duodenum cancer	0.0147	0.0147	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—SCT—duodenum cancer	0.0145	0.0145	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—SCT—duodenum cancer	0.0142	0.0142	CbGpPWpGaD
Atomoxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.0139	0.0139	CbGpPWpGaD
Atomoxetine—HTR1D—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.0138	0.0138	CbGpPWpGaD
Atomoxetine—HTR1B—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.0135	0.0135	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—GAST—duodenum cancer	0.0127	0.0127	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—SCT—duodenum cancer	0.012	0.012	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—SCT—duodenum cancer	0.0108	0.0108	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—SST—duodenum cancer	0.0106	0.0106	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—MEN1—duodenum cancer	0.0105	0.0105	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—SST—duodenum cancer	0.0105	0.0105	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—SST—duodenum cancer	0.0103	0.0103	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.0102	0.0102	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—SCT—duodenum cancer	0.00937	0.00937	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—SST—duodenum cancer	0.0089	0.0089	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—GAST—duodenum cancer	0.00874	0.00874	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—SST—duodenum cancer	0.00871	0.00871	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—GAST—duodenum cancer	0.00867	0.00867	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—GAST—duodenum cancer	0.00849	0.00849	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—SCT—duodenum cancer	0.00828	0.00828	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—SCT—duodenum cancer	0.00822	0.00822	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—SCT—duodenum cancer	0.00805	0.00805	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—GAST—duodenum cancer	0.00794	0.00794	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—GAST—duodenum cancer	0.00788	0.00788	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—SST—duodenum cancer	0.0078	0.0078	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—GAST—duodenum cancer	0.00771	0.00771	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—SCT—duodenum cancer	0.00752	0.00752	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—SCT—duodenum cancer	0.00747	0.00747	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—SCT—duodenum cancer	0.00731	0.00731	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—SST—duodenum cancer	0.00678	0.00678	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—GAST—duodenum cancer	0.00644	0.00644	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—SCT—duodenum cancer	0.0061	0.0061	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—SST—duodenum cancer	0.00599	0.00599	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—SST—duodenum cancer	0.00594	0.00594	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—GAST—duodenum cancer	0.00584	0.00584	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—SST—duodenum cancer	0.00582	0.00582	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—GAST—duodenum cancer	0.00559	0.00559	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—SCT—duodenum cancer	0.00554	0.00554	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—SST—duodenum cancer	0.00544	0.00544	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—SST—duodenum cancer	0.0054	0.0054	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—SCT—duodenum cancer	0.0053	0.0053	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—SST—duodenum cancer	0.00529	0.00529	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—GAST—duodenum cancer	0.00507	0.00507	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—SCT—duodenum cancer	0.00481	0.00481	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—GAST—duodenum cancer	0.00469	0.00469	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—GAST—duodenum cancer	0.00465	0.00465	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—GAST—duodenum cancer	0.00456	0.00456	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—SCT—duodenum cancer	0.00444	0.00444	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—SST—duodenum cancer	0.00441	0.00441	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—SCT—duodenum cancer	0.00441	0.00441	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—SCT—duodenum cancer	0.00432	0.00432	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—SST—duodenum cancer	0.00401	0.00401	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MEN1—duodenum cancer	0.00388	0.00388	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MEN1—duodenum cancer	0.00385	0.00385	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—SST—duodenum cancer	0.00383	0.00383	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MEN1—duodenum cancer	0.00377	0.00377	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—SST—duodenum cancer	0.00348	0.00348	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—GAST—duodenum cancer	0.00345	0.00345	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—SCT—duodenum cancer	0.00327	0.00327	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—SST—duodenum cancer	0.00321	0.00321	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—SST—duodenum cancer	0.00319	0.00319	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—SST—duodenum cancer	0.00312	0.00312	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—GAST—duodenum cancer	0.003	0.003	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MEN1—duodenum cancer	0.00286	0.00286	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SCT—duodenum cancer	0.00284	0.00284	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MEN1—duodenum cancer	0.00248	0.00248	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—SST—duodenum cancer	0.00237	0.00237	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—SST—duodenum cancer	0.00205	0.00205	CbGpPWpGaD
